Comparison of tryptic fragments of von Willebrand factor involved in binding to thrombin-activated platelets with fragments involved in ristocetin-induced binding and binding to collagen
- PMID: 3551182
Comparison of tryptic fragments of von Willebrand factor involved in binding to thrombin-activated platelets with fragments involved in ristocetin-induced binding and binding to collagen
Abstract
Previously we have studied the binding domains on von Willebrand factor (vWF) involved in ristocetin-induced binding to platelets (ristocetin binding domain, RBD) and in the binding of vWF to collagen (collagen binding domain, CBD) using tryptic fragments of 125I-labelled vWF (21, 23). We have also reported on the RBD, CBD and the domain on vWF involved in the binding to thrombin activated platelets (thrombin binding domain, TBD) using vWF-fragments prepared by digestion with staphylococcal protease V8 (25). In the present study, we have digested 125I-vWF with TPCK-trypsin and we have performed at various times of digestion immuno-precipitation with Mab 9, the antibody inhibiting binding of vWF to thrombin activated platelets. The data were compared with the immunoprecipitation patterns simultaneously obtained with CLB-RAg 35 which inhibits binding of vWF in the presence of ristocetin and with CLB-RAg 201, which inhibits binding of vWF to collagen. At 90 min, Mab 9 and CLB-RAg 201 precipitated similar high molecular weight bands, whereas CLB-RAg 35 precipitated bands at 180 and 120 kDa. After 24 h, Mab 9 precipitated bands at 200, 155, 116 and 85 kDa; CLB-RAg 201 precipitated a band at 48 kDa and CLB-RAg 35 a band at 116 kDa. Two-dimensional electrophoresis demonstrated that the high molecular weight bands, precipitated by Mab 9 and CLB-RAg 201 at 90 min, were identical. The 116 kDa fragment recognized by CLB-RAg 35 had a different subunit composition than the 116 kDa fragment precipitated by Mab 9.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen.J Clin Invest. 1984 Sep;74(3):736-44. doi: 10.1172/JCI111489. J Clin Invest. 1984. PMID: 6332119 Free PMC article.
-
A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.J Clin Invest. 1993 Jan;91(1):273-82. doi: 10.1172/JCI116181. J Clin Invest. 1993. PMID: 8423224 Free PMC article.
-
Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.Thromb Haemost. 1990 Oct 22;64(2):326-32. Thromb Haemost. 1990. PMID: 1702906
-
Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagen.J Clin Invest. 1988 Jul;82(1):65-73. doi: 10.1172/JCI113602. J Clin Invest. 1988. PMID: 2839553 Free PMC article.
-
[Von Willebrand factor and platelet adhesion to the subendothelium of the vascular wall].Nouv Rev Fr Hematol (1978). 1982;24(3):145-51. Nouv Rev Fr Hematol (1978). 1982. PMID: 6752879 Review. French.
Cited by
-
Platelet adhesion to collagen. Factors affecting Mg2(+)-dependent and bivalent-cation-independent adhesion.Biochem J. 1990 Jun 1;268(2):481-6. doi: 10.1042/bj2680481. Biochem J. 1990. PMID: 2114094 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous